8 results match your criteria: "Heartland Center for Reproductive Medicine[Affiliation]"
Toxicol Sci
June 2024
Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, Nebraska 68198, USA.
Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic chemicals that are resistant to biodegradation and are environmentally persistent. PFAS are found in many consumer products and are a major source of water and soil contamination. This study investigated the effects of an environmentally relevant PFAS mixture (perfluorooctanoic acid [PFOA], perfluorooctanesulfonic acid [PFOS], perfluorohexanesulfonic acid [PFHxS]) on the transcriptome and function of human granulosa cells (hGCs).
View Article and Find Full Text PDFHum Fertil (Camb)
December 2023
Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
Intrauterine insemination (IUI) is a frequently used method to treat couples with infertility. There is evidence of decreased pregnancy rates with a total motile sperm count (TMSC) of less than 10 million, yet there remains to be a consensus on semen parameters for which to recommend IUI in the infertile population. The aim of this study was to determine a minimum threshold of TMSC on semen analysis to offer IUI cycles.
View Article and Find Full Text PDFTransl Androl Urol
October 2020
Division of Urologic Surgery, University of Nebraska Medical Center, Omaha, NE, USA.
Background: Though insurance coverage is evolving for male infertility services, most patients continue to pay out of pocket. These costs such as semen analysis and intracytoplasmic sperm injection preparation may affect the utilization of those services. We sought to determine online price transparency specifically for male infertility services on the websites of in-vitro fertilization (IVF) clinics in the US.
View Article and Find Full Text PDFSci Bull (Beijing)
August 2020
Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Understanding the cell-of-origin of ovarian high grade serous cancer (HGSC) is the prerequisite for efficient prevention and early diagnosis of this most lethal gynecological cancer. Recently, a mesenchymal type of ovarian HGSC with the poorest prognosis among ovarian cancers was identified by both TCGA and AOCS studies. The cell-of-origin of this subtype of ovarian cancer is unknown.
View Article and Find Full Text PDFFASEB J
September 2019
Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital-Harvard Medical School, Boston, Massachusetts, USA.
Although the role of the Hippo signaling pathway in development and tumorigenesis has been extensively studied in multiple organs, its role in ovarian follicle development remains largely unknown. Here, we report that Yes-Associated Protein 1 (YAP1), the major effector of Hippo signaling, is spatiotemporally expressed in ovarian granulosa cells and plays a critical role in the regulation of follicle development. We found that the active form of YAP1 (nuclear YAP1) was predominantly expressed in proliferative granulosa cells, whereas the inactive form of YAP1 (cytoplasmic YAP1) was mainly detected in luteal cells (terminally differentiated granulosa cells).
View Article and Find Full Text PDFReprod Biomed Online
May 2019
Heartland Center for Reproductive Medicine, 7308 South 142nd Street, Omaha NE 68138, USA.
Research Question: What concentration of anti-Müllerian hormone (AMH) corresponds to an antral follicle count (AFC) >15 for determination of ovarian reserve?
Design: A prospective study conducted at 13 US fertility clinics in women aged 21-44 years who presented for AFC evaluation by transvaginal ultrasound. Serum samples were collected at the time of AFC evaluation (menstrual cycle day 2-4). AMH concentrations were measured by the Elecsys AMH immunoassay; oestradiol and follicle-stimulating hormone (FSH) concentrations were also measured.
J Pediatr Adolesc Gynecol
June 2016
Department of Radiation Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, Massachusetts.
Study Objective: To describe the rates of use and effectiveness of gonadotropin-releasing hormone (GnRH) agonists and other forms of hormonal menstrual suppression in prevention of vaginal bleeding among young women who underwent hematopoietic stem cell transplantation (HCT).
Design: Retrospective descriptive study.
Setting: University-based pediatric HCT practice.
Obstet Gynecol
February 2009
From the Division of Maternal Fetal Medicine, Nebraska Medical Center; and Heartland Center for Reproductive Medicine, Omaha, Nebraska.
Background: Ovarian hyperstimulation syndrome is a known complication of ovarian stimulation, particularly with injectable gonadotropins. Spontaneous ovarian hyperstimulation is rare and often involves a conformational change in the follicle-stimulating hormone receptor, increasing its binding with human chorionic gonadotropin or thyroid-stimulating hormone. Few data are available regarding the management or outcomes of spontaneous ovarian hyperstimulation syndrome.
View Article and Find Full Text PDF